Sophiris Bio, Inc.
SPHS
SPHS was delisted on the 11th of March, 2020.
14 hedge funds and large institutions have $739K invested in Sophiris Bio, Inc. in 2015 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 5 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
1% more capital invested
Capital invested by funds: $732K → $739K (+$6.72K)
22% less funds holding
Funds holding: 18 → 14 (-4)
80% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$35.8K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.8K |
| 3 |
AIG
American International Group
New York
|
+$4.87K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
+$836 |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$167 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$28K |
| 2 |
Goldman Sachs
New York
|
-$22K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
-$19K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$16K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$13K |
SPHS Hedge Fund Activity: Q3 2015 in Review
14 of the 3,583 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q3 2015, worth a combined $739K — up 0.92% from $732K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of SPHS and 1 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 4 added.
The largest buyer was Morgan Stanley, adding an estimated $35.8K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $28K sold.
- 14 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q3 2015, down from 18 in Q2 2015.
- Funds reported $739K of Sophiris Bio, Inc. stock for Q3 2015, up 0.92% quarter-over-quarter.
- 1 fund opened new Sophiris Bio, Inc. positions in Q3 2015 and 5 closed out, a net change of -4 holders.
- The largest Sophiris Bio, Inc. buyer in Q3 2015 was Morgan Stanley, an estimated $35.8K added.
- The largest Sophiris Bio, Inc. seller in Q3 2015 was Renaissance Technologies, an estimated $28K sold.
Based on aggregated 13F filings for Q3 2015.